Allurion Technologies Appoints New Director, Reports Officer Compensation
Ticker: ALURW · Form: 8-K · Filed: Sep 4, 2024 · CIK: 1964979
Sentiment: neutral
Topics: governance, officer-compensation, board-changes
TL;DR
Allurion board shakeup: O'Malley out, Weitz in. Officer comp details also filed.
AI Summary
Allurion Technologies, Inc. filed an 8-K on September 4, 2024, reporting on the departure of Director Michael J. O'Malley and the appointment of Dr. Jonathan L. Weitz as a new director, effective September 2, 2024. The filing also disclosed compensatory arrangements for certain officers and included financial statements and exhibits.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, while disclosures on officer compensation provide insight into executive incentives.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance changes and disclosures, with no immediate financial distress or significant operational shifts indicated.
Key Players & Entities
- Michael J. O'Malley (person) — Departing Director
- Dr. Jonathan L. Weitz (person) — Appointed Director
- Allurion Technologies, Inc. (company) — Registrant
- September 02, 2024 (date) — Effective date of director change
- September 4, 2024 (date) — Filing date of the 8-K
FAQ
Who has departed from the Board of Directors of Allurion Technologies, Inc.?
Michael J. O'Malley has departed from the Board of Directors.
Who has been appointed as a new director to Allurion Technologies, Inc.'s Board?
Dr. Jonathan L. Weitz has been appointed as a new director.
When were the changes to the Board of Directors effective?
The changes were effective as of September 02, 2024.
What other items are covered in this 8-K filing?
The filing also covers compensatory arrangements of certain officers and includes financial statements and exhibits.
What is the filing date of this Current Report?
The filing date is September 04, 2024.
Filing Stats: 606 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-09-04 18:24:43
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share ALUR The New York Stock E
- $8.10 — mon stock, each at an exercise price of $8.10 per share of common stock ALUR WS T
Filing Documents
- alur-20240902.htm (8-K) — 45KB
- alur-ex99_1.htm (EX-99.1) — 15KB
- img255759453_0.jpg (GRAPHIC) — 9KB
- 0000950170-24-103546.txt ( ) — 227KB
- alur-20240902.xsd (EX-101.SCH) — 47KB
- alur-20240902_htm.xml (XML) — 7KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release issued by the registrant on September 3, 2024, furnished herewith. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALLURION TECHNOLOGIES, INC. Date: September 4, 2024 By: /s/ Brendan Gibbons Name: Title: Brendan Gibbons Chief Legal Officer